Arginase 1: An unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury

Frontiers in Immunology

Volumn 4, Issue AUG, 2013, Pages

  Lucas, Rudolf ^a   Czikora, Istvàn ^a   Sridhar, Supriya ^a   Zemskov, Evgeny A ^a   Oseghale, Aluya ^a   Circo, Sebastian ^a   Cederbaum, Stephen D ^b   Chakraborty, Trinad ^c   Fulton, David J ^a   Caldwell, Robert W ^a   Romero, Maritza J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Arginase 1; Capillary leak; Endothelial nitric oxide synthase; Pneumolysin; Pneumonia

Indexed keywords

ARGINASE 1; BACTERIAL TOXIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN LIGHT CHAIN; PNEUMOLYSIN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C RECEPTOR; THIOREDOXIN 1;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY ENDOTHELIAL CELL; CAPILLARY LEAK SYNDROME; ENZYME ACTIVITY; GAS EXCHANGE; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PNEUMONIA; PROTEIN PHOSPHORYLATION; PULMONARY CAPILLARY BARRIER DYSFUNCTION;

EID: 84883663145     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00228     Document Type: Article

References (70)

1. Lucas R, Verin A, Black SA, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharm (2009) 77:1763-72. doi:10.1016/j.bcp.2009.01.014
2. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap? Mol Genet Metab (2004) 1:S38-44. doi:10.1016/j.ymgme.2003.10.012
3. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol (2008) 378:171-84. doi:10.1007/s00210-008-0286-7
4. Carraway MS, Piantadosi CA, Jenkinson CP, Huang YC. Differential expression of arginase and iNOS in the lung in sepsis. Exp Lung Res (1998) 24:253-68. doi:10.3109/01902149809041533
5. Klasen S, Hammermann R, Fuhrmann M, Lindemann D, Beck KF, Pfeilschifter J, et al. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 132:1349-57. doi:10.1038/sj.bjp.0703951
6. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med (2005) 38:1543-52. doi:10.1016/j.freeradbiomed.2005.02.026
7. Song JY, Kim KD, Roe JH. Thiol-independent action of mitochondrial thioredoxin to support the urea cycle of arginine biosynthesis in Schizosaccharomyces pombe. Eukaryot Cell (2008) 7(12):2160-7. doi:10.1128/EC.00106-08
8. McGee DJ, Kumar S, Viator RJ, Bolland JR, Ruiz J, Spadafora D, et al. Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses. J Biol Chem (2006) 281(6):3290-6. doi:10.1074/jbc.M506139200
9. Billiet L, Furman C, Larigauderie G, Copin C, Brand K, Fruchart JC, et al. Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages. J Biol Chem (2005) 280:40310-8. doi:10.1074/jbc.M503644200
10. Billiet L, Rouis M. Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets (2008) 8(4):293-6. doi:10.2174/187152908786786179
11. Matsuo Y, Yodoi J. Extracellular thioredoxin: a therapeutic tool to combat inflammation. Cytokine Growth Factor Rev (2013). doi:10.1016/j.cytogfr.2013.01.001
12. Nakamura H, Hoshino Y, Okuyama H, Matsuo Y, Yodoi J. Thioredoxin 1 delivery as new therapeutics. Adv Drug Deliv Rev (2009) 61:303-9. doi:10.1016/j.addr.2009.01.003
13. Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal (2005) 7:60-71. doi:10.1089/ars.2005.7.60
14. Yashiro M, Tsukahara H, Matsukawa A, Yamada M, Fujii Y, Nagaoka Y, et al. Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice. Crit Care Med (2013) 41:166-76. doi:10.1097/CCM.0b013e3182676352
15. Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, Malkinson AM. Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol (2010) 88:159-68. doi:10.1189/jlb.0609378
16. Feola DJ, Garvy BA, Cory TJ, Birket SE, Hoy H, Hayes D Jr., et al. Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. Antimicrob Agents Chemother (2010) 54:2437-47. doi:10.1128/AAC.01424-09
17. Rodríguez N, Mages J, Dietrich H, Wantia N, Wagner H, Lang R, et al. MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol Genomics (2007) 30:134-45. doi:10.1152/physiolgenomics.00011.2007
18. Maarsingh H, Dekkers BG, Zuidhof AB, Bos IS, Menzen MH, Klein T, et al. Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J (2011) 38:318-28. doi:10.1183/09031936.00057710
19. Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS, Rey-Parra GJ, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol (2012) 303:L967-77. doi:10.1152/ajplung.00144.2011
20. Roy RM, Wüthrich M, Klein BS. Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. J Immunol (2012) 189:2545-52. doi:10.4049/jimmunol.1200689
21. Jiang J, George SC. TGF-β2 reduces nitric oxide synthase mRNA through a ROCK-dependent pathway in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2010) 301:L361-7. doi:10.1152/ajplung.00464.2010
22. Ckless K, van der Vliet A, Janssen-Heininger Y. Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism. Am J Respir Cell Mol Biol (2007) 36:645-53. doi:10.1165/rcmb.2006-0329SM
23. Ckless K, Lampert A, Reiss J, Kasahara D, Poynter ME, Irvin CG, et al. Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol (2008) 181:4255-64.
24. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol (2001) 91:1487-500.
25. Kolosova IA, Ma SF, Adyshev DM, Wang P, Ohba M, Natarajan V, et al. Role of CPI-17 in the regulation of endothelial cytoskeleton. Am J Physiol Lung Cell Mol Physiol (2004) 287:L970-80. doi:10.1152/ajplung.00398.2003
26. Kim KM, Adyshev DM, Kása A, Zemskov EA, Kolosova IA, Csortos C, et al. Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening. Microvasc Res (2013) 88:19-24. doi:10.1016/j.mvr.2013.04.002
27. Birukova AA, Birukov KG, Adyshev D, Usatyuk P, Natarajan V, Garcia JG, et al. Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction. J Cell Physiol (2005) 204:934-47. doi:10.1002/jcp.20359
28. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci (2008) 1123:134-45. doi:10.1196/annals.1420.016
29. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol (2003) 28:574-81. doi:10.1165/rcmb.2002-0075OC
30. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ (2008) 86:408-16. doi:10.2471/BLT.07.048769
31. Gutiérrez F, Masiá M. Improving outcomes of elderly patients with community-acquired pneumonia. Drugs Aging (2008) 25:585-610. doi:10.2165/00002512-200825070-00005
32. Waterer GW, Rello J, Wunderink RG. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med (2011) 183:157-64. doi:10.1164/rccm.201002-0272CI
33. Rubins JB, Charboneau D, Fasching C, Berry AM, Paton JC, Alexander JE, et al. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med (1996) 153:1339-46. doi:10.1164/ajrccm.153.4.8616564
34. Witzenrath M, Gutbier B, Hocke AC, Schmeck B, Hippenstiel S, Berger K. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit Care Med (2006) 34:1947-54. doi:10.1097/01.CCM.0000220496.48295.A9
35. Anderson R, Steel HC, Cockeran R, von Gottberg A, de Gouveia L, Klugman KP, et al. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother (2007) 60:1155-8. doi:10.1093/jac/dkm338
36. Maus U, Srivastava M, Paton JC, Mack M, Everhart MB, Blackwell TS, et al. Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J Immunol (2004) 173:1307-12.
37. Stringaris AK, Geisenhainer J, Bergmann F, Balshüsemann C, Lee U, Zysk G, et al. Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol Dis (2002) 11:355-68. doi:10.1006/nbdi.2002.0561
38. Sandoval R, Malik AB, Minshall RD, Kouklis P, Ellis CA, Tiruppathi C. Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol (2001) 533:433-45. doi:10.1111/j.1469-7793.2001.0433a.x
39. Siflinger-Birnboim A, Johnson A. Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 284:L435-51.
40. Mehta D, Rahman A, Malik AB. Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem (2001) 276:22614-20. doi:10.1074/jbc.M101927200
41. Harrington EO, Brunelle JL, Shannon CJ, Kim ES, Mennella K, Rounds S. Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. Am J Respir Cell Mol Biol (2003) 28:626-36. doi:10.1165/rcmb.2002-0085OC
42. Dworakowski R, Alom-Ruiz SP, Shah AM. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep (2008) 60:21-8.
43. Chen F, Haigh S, Barman S, Fulton DJ. From form to function: the role of Nox4 in the cardiovascular system. Front Physiol (2012) 3:412. doi:10.3389/fphys.2012.00412
44. Xu H, Goettsch C, Xia N, Horke S, Morawietz H, Förstermann U, et al. Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med (2008) 44:1656-67. doi:10.1016/j.freeradbiomed.2008.01.023
45. Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, et al. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine. Vascul Pharmacol (2010) 52:182-90. doi:10.1016/j.vph.2009.11.010
46. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res (2008) 102:95-102. doi:10.1161/CIRCRESAHA.107.155028
47. Beleznai T, Feher A, Spielvogel D, Lansman SL, Bagi Z. Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am J Physiol Heart Circ Physiol (2011) 300:H777-83. doi:10.1152/ajpheart.00831.2010
48. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol (2006) 147(1):S193-201. doi:10.1038/sj.bjp.0706458
49. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol (2005) 289:L371-81. doi:10.1152/ajplung.00175.2004
50. Worrall NK, Chang K, LeJeune WS, Misko TP, Sullivan PM, Ferguson TB Jr., et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol (1997) 273:H2565-74.
51. Speyer CL, Neff TA, Warner RL, Guo RF, Sarma JV, Riedemann NC, et al. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am J Pathol (2003) 163:2319-28. doi:10.1016/S0002-9440(10)63588-2
52. Min JK, Cho YL, Choi JH, Kim Y, Kim JH, Yu YS, et al. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood (2007) 109:1495-502. doi:10.1182/blood-2006-06-029298
53. White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D, et al. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension (2006) 47:245-51. doi:10.1161/01.HYP.0000198543.34502.d7
54. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta (1999) 1411:217-30. doi:10.1016/S0005-2728(99)00016-X
55. Lin MI, Fulton D, Babbitt R, Fleming I, Busse R, Pritchard KA Jr., et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production. J Biol Chem (2003) 278:44719-26. doi:10.1074/jbc.M302836200
56. Lucas R, Yang G, Gorshkov BA, Zemskov EA, Sridhar S, Umapathy NS, et al. Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am J Respir Cell Mol Biol (2012) 47:445-53. doi:10.1165/rcmb.2011-0332OC
57. Peng J, He F, Zhang C, Deng X, Yin F. Protein kinase C-α signals P115RhoGEF phosphorylation and RhoA activation in TNF-α-induced mouse brain microvascular endothelial cell barrier dysfunction. J Neuroinflammation (2011) 8:28. doi:10.1186/1742-2094-8-28
58. Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB, Caldwell RW. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol (2012) 165(2):506-19. doi:10.1111/j.1476-5381.2011.01584.x
59. Shatanawi A, Romero MJ, Iddings JA, Chandra S, Umapathy NS, Verin AD, et al. Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. Am J Physiol Cell Physiol (2011) 300(5):C1181-92. doi:10.1152/ajpcell.00328.2010
60. Deignan JL, Livesay JC, Yoo PK, Goodman SI, O'Brien WE, Iyer RK, et al. Ornithine deficiency in the arginase double knockout mouse. Mol Genet Metab (2006) 89:87-96. doi:10.1016/j.ymgme.2006.04.007
61. Helms MN, Yu L, Malik B, Kleinhenz DJ, Hart CM, Eaton DC. Role of SGK1 in nitric oxide inhibition of ENaC in Na+-transporting epithelia. Am J Physiol Cell Physiol (2005) 289:C717-26. doi:10.1152/ajpcell.00006.2005
62. Berthiaume Y, Matthay MA. Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol (2007) 159:350-9. doi:10.1016/j.resp.2007.05.010
63. Gordon S. Alternative activation of macrophages. Nat Rev Immunol (2003) 3:23-35. doi:10.1038/nri978
64. Yang L, Qiao G, Ying H, Zhang J, Yin F. TCR-induced Akt serine 473 phosphorylation is regulated by protein kinase C-alpha. Biochem Biophys Res Commun (2010) 400:16-20. doi:10.1016/j.bbrc.2010.07.126
65. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol (1999) 17:331-67. doi:10.1146/annurev.immunol.17.1.331
66. Hundsberger H, Verin A, Wiesner C, Pflueger M, Dulebo A, Schuett W, et al. TNF: a moonlighting protein at the interface between cancer and infection. Front Biosci (2008) 13:5374-86.
67. Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattaliano RJ, et al. Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science (1987) 237:1479-84. doi:10.1126/science.3498215
68. Sherblom AP, Decker JM, Muchmore AV. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem (1988) 263:5418-24.
69. Lucas R, Magez S, De Leys R, Fransen L, Scheerlinck JP, Rampelberg M, et al. Mapping the lectin-like activity of tumor necrosis factor. Science (1994) 263:814-7. doi:10.1126/science.8303299
70. Lucas R, Sridhar S, Rick FG, Gorshkov B, Umapathy NS, Yang G, et al. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc Natl Acad Sci U S A (2012) 109:2084-9. doi:10.1073/pnas.1121075109